Léim ar aghaidh chuig an bpríomhábhar
Gnáthamharc

Medicinal Products Supply

Dáil Éireann Debate, Thursday - 27 June 2013

Thursday, 27 June 2013

Ceisteanna (279)

Caoimhghín Ó Caoláin

Ceist:

279. Deputy Caoimhghín Ó Caoláin asked the Minister for Health if he will provide an update in the work undertaken by the national task force on prescribing and dispensing; the savings expected to be delivered by this approach; and if he will make a statement on the matter. [31428/13]

Amharc ar fhreagra

Freagraí scríofa

The HSE has been working with GPs over many years to encourage better quality prescribing of drugs in Ireland. In 2012, the HSE's Medicines Management Programme was established and one of its key tasks is to communicate with prescribers regarding best practice.

The Programme has identified 'preferred drugs' for prescribers when prescribing Proton Pump Inhibitors (PPIs) or statin medication for patients. This is the first time that the State has introduced a preferred drug initiative. PPIs are prescribed for patients with peptic ulcer disease and/or reflux and statin medication is for high cholesterol. The preferred PPI is Lansoprazole and the preferred statin is Simvastatin. The HSE is asking doctors to prescribe these preferred drugs in order to save money, both for patients who pay for their medication and to deliver savings of an estimated €15million for the taxpayer.

A further initiative underway to assist with GP prescribing is the launch of the HSE's Prescribing Guidance System (PGS). This system supports prescribers with integrated 'point of prescribing' information making it easier for GPs to make decisions in line with MMP prescribing guidance. In turn, the system also gives assurance regarding the effectiveness of prescribing guidance interventions.

It is anticipated that this prescribing guidance system will be a critical assistance to the GP community and significantly important to the wider health system.

Barr
Roinn